Canada · Delayed Price · Currency is CAD Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of CAD 401.66 billion. The enterprise value is 433.41 billion.
| Market Cap | 401.66B |
| Enterprise Value | 433.41B |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Dec 15, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.34% |
| Shares Change (QoQ) | -0.40% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 78.92% |
| Float | 2.48B |
Valuation Ratios
The trailing PE ratio is 16.05 and the forward PE ratio is 22.95.
| PE Ratio | 16.05 |
| Forward PE | 22.95 |
| PS Ratio | 4.51 |
| PB Ratio | 5.64 |
| P/TBV Ratio | 19.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 17.32 |
| EV / Sales | 4.87 |
| EV / EBITDA | 11.01 |
| EV / EBIT | 12.93 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | n/a |
| Interest Coverage | 18.06 |
Financial Efficiency
Return on equity (ROE) is 37.17% and return on invested capital (ROIC) is 28.30%.
| Return on Equity (ROE) | 37.17% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 28.30% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.20M |
| Profits Per Employee | 338,222 |
| Employee Count | 75,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Merck & Co. has paid 3.84 billion in taxes.
| Income Tax | 3.84B |
| Effective Tax Rate | 13.31% |
Stock Price Statistics
The stock price has increased by +14.54% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +14.54% |
| 50-Day Moving Average | 23.83 |
| 200-Day Moving Average | 20.07 |
| Relative Strength Index (RSI) | 73.62 |
| Average Volume (20 Days) | 5,485 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.34 |
Income Statement
In the last 12 months, Merck & Co. had revenue of CAD 89.14 billion and earned 25.03 billion in profits. Earnings per share was 9.98.
| Revenue | 89.14B |
| Gross Profit | 68.71B |
| Operating Income | 33.60B |
| Pretax Income | 28.89B |
| Net Income | 25.03B |
| EBITDA | 39.48B |
| EBIT | 33.60B |
| Earnings Per Share (EPS) | 9.98 |
Balance Sheet
The company has 24.97 billion in cash and 56.73 billion in debt, with a net cash position of -31.76 billion.
| Cash & Cash Equivalents | 24.97B |
| Total Debt | 56.73B |
| Net Cash | -31.76B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 71.17B |
| Book Value Per Share | 28.58 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 77.08%, with operating and profit margins of 37.69% and 28.08%.
| Gross Margin | 77.08% |
| Operating Margin | 37.69% |
| Pretax Margin | 32.41% |
| Profit Margin | 28.08% |
| EBITDA Margin | 44.30% |
| EBIT Margin | 37.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.74, which amounts to a dividend yield of 2.78%.
| Dividend Per Share | 0.74 |
| Dividend Yield | 2.78% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 1.34% |
| Shareholder Yield | 4.12% |
| Earnings Yield | 6.23% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |